-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
ReShape Lifesciences Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q2 2025.
- ReShape Lifesciences Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 1.17M shares, a 6609% increase year-over-year.
- ReShape Lifesciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 516K shares, a 402% increase from 2023.
- ReShape Lifesciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 103K shares, a 75.8% decline from 2022.
- ReShape Lifesciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 424K shares, a 94.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)